News +

Media

Article

CyGenica Presented in Intracellular Drug Delivery Summit 2023 , March 8-9, 2023, Boston “ Achieve Therapeutic Localization with Selective , Effective and Validated Delivery to Intracellular Targets”

CyGenica is at BIO ASIA “Advancing for One”, 24th-26th Februaury 2023, Hyderabad. Please meet us at P63. Lets explore the partnership opportunities.

Our Founder and Chief Executive Officer Dr Nusrat J M Sanghamitra will be attending BIO 2023 International Convention Monday, Jun 5, 2023 —Thursday, Jun 8, 2023 Boston Convention and Exhibition Center (415 Summer St, Boston, MA 02210) in the Seaport District of Boston, MA.

CyGenica Limited Secures USFDA Approval for Orphan Drug Designation for Novel Drug Conjugate in Glioblastoma Multiforme Treatment

CyGenica Chosen for Prestigious CDL Programme, Paving the Way for biotech Innovation nurturing an entrepreneurial mindset through expert opinion, funding opportunities, research analysis, and business development support.

CyGenica presenting at Bio CEO and Investor Conference 2024: Connecting network for Strategic Partnerships for “ Making molecular delivery effortless and efficient”

Our Founder and Chief Executive Officer Dr Nusrat J M Sanghamitra will be presenting MedInvest Oncology Investor Conference, June 21-23, 2023, Boston

CyGenica IS ATTENDING LONGEVITY LEADERS WORLD CONGRESS 2022, APRIL 26-27 2022 IN LONDON

Our CEO Dr. Nusrat Sanghmitra will pleased to be in London in April (26-27) for the Longevity Leaders World Congress 2022. She is looking forward to meeting with international leaders of the biotech industry.

CyGenica IS ATTENDING 5TH ANNUAL LSX WORLD CONGRESS USA 2022, JUNE 21-22, 2022 IN BOSTON

Our CEO Dr. Nusrat Sanghmitra will pleased to be in Boston in June (21-22) for the 5th Annual LSX World Congress USA 2022. She is looking forward to meeting with international leaders of the biotech industry.

CyGenica has been featured at GLOBALGOALSCAST

CyGenica Featured in biopharmadealmakers, September 2021

Indo-Irish Biotech startup CyGenica secures funding from SOSV to accelerate cancer and rare genetic disease therapy

‘FedEx’ for cancer medicine, Cyca OncoSolutions wants to reduce the side effects of treatment

City-based Start-up brings a ray of hope for cancer patients

Award-winning researcher and scientist Dr Nusrat Sanghamitra talks about Chemistry, her cancer research and its benefits.

Cyca Onco Solutions emerges as best startup at She Loves Tech award

Odisha’s Nusrat Sanghamitra Awarded In China For Path-Breaking Cancer Research

Special Startup Series: The quest for safer cancer cure

Presented in BioPharma India 2017

Featured In: Indian Biotech sector readies for lift off

Featured In: Cancer Warrior

Achieving Milestones Of Success

Winner of Rubicons Award

Woman entrepreneur from Odisha awarded in China for groundbreaking anti-cancer innovation

Most Innovative Business Idea

Videos

Subroto Bagchi with CyGenica CEO & CSO Nusrat Sanghamitra

CEO, CyGenica speaking during 75 for 75 Platinum Jubilee Celebrations of SCB Medical colllege

CyCa Oncosolutions - Nusrat Jahan pitches at RebelBio Demo Day 2017 - Imperial College, London

Interview with CEO of CyCa OncoSolutions by Natascha McQueen Head of Production QITV Ltd.

Featured in

Foresight Institute
Technology development board
RICH
She loves tech
FICCI
iigp
VENTURE center
KiiT- TBI

Photo Gallery

i3 Gold Award for Top Innovator 2017 by DST-CII-AICTE

Dr Nusrat J Sanghamitra, CEO with Dr Renu Swarup, Secretary, DBT, Govt of India

IIGP Award

She loves Tech

© 2024️ CYGENICA. ALL RIGHTS RESERVE